Search

Search Constraints

You searched for: Author/Creator Wölfl, Matthias

Search Results

1. Characterization of a novel OTX2‐driven stem cell program in Group 3 and Group 4 medulloblastoma. Issue 4 (1st March 2018)

2. Fulminant skin GvHD with a cytokine pattern resemblant of cytokine release syndrome successfully treated with multimodal immunosuppression including tocilizumab. Issue 11 (7th July 2015)

4. IMMU-07. Interim analysis of the HIT-HGG Rez Immunvac study - Dendritic cell vaccination with partial Treg depletion and double checkpoint blockade in children with relapsed high-grade gliomas. (3rd June 2022)

5. IMMU-10. INTERIM ANALYSIS OF THE HIT-HGG REZ IMMUNVAC STUDY - DENDRITIC CELL VACCINATION WITH PARTIAL TREG DEPLETION IN CHILDREN, ADOLESCENTS, AND ADULTS WITH RELAPSED HIGH-GRADE GLIOMAS. (4th December 2020)

6. IMMU-28. DECIPHERING THE AT/RT LIGANDOME. Issue 2 (22nd June 2018)

8. MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-properties. Issue 1 (December 2016)

10. Role of B cells in chronic graft‐versus‐host disease after allogeneic stem cell transplantation in children and adolescents. (28th May 2019)